logo-loader
viewGenedrive PLC

Genedrive CEO hails 'excellent' result from hepatitis-C study in India, a key target market

The work was carried out by Dr Ekta Gupta at the Institute of Liver and Biliary Sciences, New Delhi

Genedrive PLC -

Genedrive PLC (LON:GDR) chief executive David Budd hailed as 'excellent'  the results from an Indian study that showed the group's hepatitis-C (HCV) testing kit was able to determine who did and didn’t have the disease with 100% accuracy.

Overall, the data demonstrated that the rapid point-of-care device was suitable for use in a country where infections estimated at between six and 12 million, the company added.

"These excellent clinical results for our HCV assay further validate the applicability of the test for a decentralised setting,” explained Budd. “India is a key target market for our assay and we are excited about the commercial prospects in the region."

The work was carried out by Dr Ekta Gupta at the Institute of Liver and Biliary Sciences, New Delhi, who assessed 320 people (150 of whom were HCV-positive) using the portable diagnostic device.

Accuracy was measured by comparing the Genedrive results with those from the lab-based Abbott m2000 platform.

The assessment carried out across a demographic range using different genotypes, “to ensure suitability for the introduction of the product to the Indian population”.

For more information click here. 

Quick facts: Genedrive PLC

Price: 57 GBX

AIM:GDR
Market: AIM
Market Cap: £32.18 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Genedrive PLC named herein, including the promotion by the Company of Genedrive PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Market report: FTSE falls as hopes of US stimulus package before election wanes

FTSE 100 opened lower amid continued scepticism about a US stimulus package before next month’s election. London’s index of big caps dived 40 points to 5,735 in early trading.   Chancellor Rishi Sunak is expected to announce more support for workers in areas placed under tier 2 of local...

on 22/10/20

2 min read